Abstract
Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have